By Plenary Sessions: Madis Timpson
Total Sessions: 4
Fully Profiled: 4
2024-10-23
15th Riigikogu, 4th sitting, plenary session
Demonstrates comprehensive knowledge of the rules of procedure for the Riigikogu committee, including the voting outcomes of procedural decisions and the formal recording of minutes. Their professional expertise encompasses the legal framework for pharmaceutical reserves, citing the National Audit Office's remarks on the lawfulness of the existing structure. Furthermore, they are familiar with the economic impact of increasing state fees, pointing out the additional cost (€79,000) in proportion to the total volume of the pharmaceutical market (€400 million).
2024-10-17
15th Riigikogu, 4th sitting, plenary sitting
The speaker frankly admits they are new to the Riigikogu ("This is my first time in the Riigikogu") and therefore relies on the presenter's knowledge to explain the history of the draft bill. The speech does not demonstrate specific, in-depth knowledge of the topic; instead, the speaker seems to be seeking background information.
2024-10-10
Fifteenth Riigikogu, Fourth sitting, plenary session.
Expertise lies in the work organization and legislative procedures of the Social Affairs Committee, particularly when suspending the readings of draft legislation. The technical term "consensus proposal" is utilized, and reference is made to Bill number 427, which demonstrates authority in communicating the committee's decisions.
2024-10-09
Fifteenth Riigikogu, Fourth Session, Plenary Session.
It demonstrates expertise in the organization of the work of the Social Affairs Committee and the handling of legislation, detailing who participated in the discussions and what questions were asked. It possesses knowledge of the financing mechanisms of the Health Insurance Fund, the impact of collective agreements on service prices, and the proposal to increase the co-payment for specialized welfare services. The expertise lies in the accurate conveyance of information and adherence to procedural rules.